Concord Wealth Partners Merck & Co., Inc. Transaction History

Concord Wealth Partners

$673 Million
Q2 2025

A detailed history of Concord Wealth Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 2,056 shares of MRK stock, worth $172,827. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,056

Previous 1,529 34.47%

Holding current value

$172,827

Previous $137,000 18.25%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	BUY	$73.47 - $87.12 $38,718 - $45,912	527 Added 34.47%	2,056 $162,000
Q1 2025 May 02, 2025	SELL	$83.01 - $101.02 $1.77 Million - $2.15 Million	-21,280 Reduced 93.3%	1,529 $137,000
Q4 2024 Jan 23, 2025	SELL	$96.31 - $114.76 $2.07 Million - $2.47 Million	-21,488 Reduced 48.51%	22,809 $2.27 Million
Q3 2024 Oct 24, 2024	BUY	$111.15 - $128.97 $1.11 Million - $1.29 Million	9,991 Added 29.12%	44,297 $5.03 Million
Q2 2024 Jul 31, 2024	BUY	$123.8 - $132.96 $300,091 - $322,295	2,424 Added 7.6%	34,306 $4.25 Million
Q1 2024 Apr 30, 2024	BUY	$113.24 - $131.95 $372,786 - $434,379	3,292 Added 11.51%	31,882 $4.21 Million
Q4 2023 Apr 30, 2024	BUY	$100.18 - $109.02 $443,997 - $483,176	4,432 Added 18.35%	28,590 $3.12 Million
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $443,997 - $483,176	4,432 Added 18.35%	28,590 $3.12 Million
Q3 2023 Apr 30, 2024	SELL	$102.95 - $114.33 $456,274 - $506,710	-4,432 Reduced 15.5%	24,158 $2.49 Million
Q3 2023 Oct 25, 2023	BUY	$102.95 - $114.33 $314,100 - $348,820	3,051 Added 14.45%	24,158 $2.49 Million
Q2 2023 Aug 07, 2023	BUY	$108.61 - $118.38 $876,265 - $955,089	8,068 Added 61.88%	21,107 $2.44 Million
Q1 2023 Apr 26, 2023	BUY	$102.94 - $114.86 $516,038 - $575,793	5,013 Added 62.46%	13,039 $1.39 Million
Q4 2022 Jan 27, 2023	SELL	$87.44 - $112.11 $234,688 - $300,903	-2,684 Reduced 25.06%	8,026 $890,000
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $16,229 - $18,232	-192 Reduced 1.76%	10,710 $922,000
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $75,307 - $85,365	902 Added 9.02%	10,902 $994,000
Q1 2022 Apr 20, 2022	BUY	$73.51 - $82.4 $61,821 - $69,298	841 Added 9.18%	10,000 $820,000
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $410,694 - $514,448	5,682 Added 163.42%	9,159 $702,000
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $235,038 - $258,483	-3,279 Reduced 48.53%	3,477 $261,000
Q2 2021 Jul 29, 2021	BUY	$70.31 - $77.77 $84,512 - $93,479	1,202 Added 21.64%	6,756 $525,000
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $255,677 - $301,161	3,713 Added 201.68%	5,554 $428,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $132,128 - $146,635	1,841 New	1,841 $151,000

Others Institutions Holding MRK

# of Institutions

3,886

Shares Held

1.93B

Call Options Held

25.6M

Put Options Held

24M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $213B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Account

Concord Wealth Partners Merck & Co., Inc. Transaction History